Home/Companies/CIK 0000057725
L
ISSUER//CIK 0000057725

LANNETT CO INC

Exchange

Entity type

operating

Fiscal year end

Jun 30

Headquarters

DE

Research Summary

AI-assisted · Grounded in filings

Updated Nov 24, 2025

LANNETT CO INC

Lannett Co. Inc. is a specialty pharmaceutical manufacturer best known for generic tablets and capsules, serving hospitals, health systems, chain pharmacies, and pharmacy benefit managers that rely on steady, competitively priced alternatives to branded drugs; its portfolio spans pain relief, cardiovascular, CNS, respiratory, and hormonal therapies built in FDA-approved facilities where ongoing compliance with GMP and evolving regulations shapes every launch. Operating within SIC 2834 (Pharmaceutical Preparations), the company must continuously manage material risks tied to complex supply chains, pricing pressures, and the regulatory scrutiny that accompanies approval and inspection cycles, particularly as new or pending filings demand detailed explanations of safety, effectiveness, and manufacturing controls. While the most recent filing is currently unspecified, the firm’s disclosures remain essential for tracking approval updates, litigation, and working capital trends, especially given the absence of a public ticker symbol. CIK 57725 anchors all of this reporting, so follow along to view live SEC filings on Earnings Feed.

Related Pharmaceutical Preparations Companies